
    
      The investigators will conduct a one-year randomized, controlled study to evaluate the impact
      of an early, integrated palliative care services. The intervention will include comprehensive
      palliative care services delivered in conjunction with standard oncology care and patient
      friendly materials for high risk oncology patients. The investigators primary clinical
      endpoint will be health related quality of life, specifically focusing on measures of
      anxiety, depression, and well-being.

      Secondary personalized palliative care outcomes are expected to include:

        -  Reduced deviations from care plan as captured in the medical record compared to the
           group who did not receive early, integrated palliative care services

        -  Reduced hospital utilization compared to the group who did not receive early, integrated
           palliative care services
    
  